EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway

Miao Zhang, Xinyu Pan, Yuanfang He, Kairong Sun, Zhiyu Wang, Weiyu Tian, Haonan Qiu, Yiqi Wang, Chengping Wen, Juan Chen iD

Biomolecules · 2025

DOI: 10.3390/biom15081078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Miao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou 310000, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, Atherosclerosis, Lupus Erythematosus, Systemic, Artesunate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, Joint Fund of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is characterized by autoimmune dysregulation, elevated autoantibody production, and persistent inflammation, predisposing patients to atherosclerosis (AS). Atherogenesis is dependent on lipid homeostasis and inflammatory processes, with the formation of lipid-laden, macrophage-derived foam cells (MDFC) essential for atherosclerotic lesion progression. Elevated cholesterol levels within lipid rafts trigger heightened pro-inflammatory responses in macrophages via Toll-like receptor 9 (TLR9). Artesunate (ART), an artemisinin derivative sourced from Artemisia annua, exhibits therapeutic potential in modulating inflammation and autoimmune conditions. Nonetheless, its impact and mechanisms in SLE-associated AS (SLE-AS) remain largely unexplored. Our investigation demonstrated that ART could effectively ameliorate lupus-like symptoms and atherosclerotic plaque development in SLE-AS mice. Moreover, ART enhanced cholesterol efflux from MDFC by upregulating ABCA1, ABCG1, and SR-B1 both in vivo and in vitro. Moreover, ART reduced cholesterol accumulation in bone marrow-derived macrophages (BMDMs), thereby diminishing TLR9 recruitment to lipid rafts. ART also suppressed TLR9 expression and its downstream effectors in the kidney and aorta of SLE-AS mice, attenuating the TLR9-mediated inflammatory cascade in CPG2395 (ODN2395)-stimulated macrophages. Through bioinformatics analysis and experimental validation, PPARγ was identified as a pivotal downstream mediator of ART in macrophages. Depleting PPARγ levels reduced the expression of ABCA1, ABCG1, and SR-B1 in macrophages, consequently impeding cholesterol efflux. In conclusion, these findings suggest that ART ameliorates SLE-AS by restoring cholesterol homeostasis through the PPARγ-ABCA1/ABCG1/SR-B1 pathway and suppressing lipid raft-driven TLR9/MyD88 inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 9AtherosclerosisLupus Erythematosus, SystemicArtesunateMyeloid Differentiation Factor 88CholesterolMembrane MicrodomainsPPAR gammaAnimalsMiceSignal TransductionMice, Inbred C57BLMacrophagesATP Binding Cassette Transporter 1

Stichwörter der Autor:innen

SLE atherosclerosisTLR9/MyD88cholesterol effluxcholesterol homeostasisinflammationlipid raft

Substanzen

Toll-Like Receptor 9ArtesunateMyeloid Differentiation Factor 88CholesterolPPAR gammaTlr9 protein, mouseMyd88 protein, mouseATP Binding Cassette Transporter 1

Autor:innen und Institutionen

  • Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou 310000, China.
  • Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, Hangzhou 310000, China.
  • Zhejiang Provincial Zhongshan Hospital, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310000, China.
  • The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310000, China.
  • Ningbo Taikang Hospital, Ningbo 315000, China.
  • The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310029, China.

ORCID-Profile: Juan Chen

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China
  • Joint Fund of the National Natural Science Foundation of China
  • he Zhejiang Chinese Medicine University Scientific Research Fund Project
  • Zhejiang Chinese Medicine University Scientific Research Fund Project

Zitieren

APA

Zhang, M., Pan, X., He, Y., Sun, K., Wang, Z., Tian, W., Qiu, H., Wang, Y., Wen, C., & Chen, J. (2025). Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway. Biomolecules. https://doi.org/10.3390/biom15081078

Vancouver

Zhang M, Pan X, He Y, Sun K, Wang Z, Tian W, et al. Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway. Biomolecules. 2025. doi:10.3390/biom15081078

BibTeX
@article{Zhang2025,
  author = {Zhang, Miao and Pan, Xinyu and He, Yuanfang and Sun, Kairong and Wang, Zhiyu and Tian, Weiyu and Qiu, Haonan and Wang, Yiqi and Wen, Chengping and Chen, Juan},
  title = {Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15081078}
}
Kostenlos starten →